2013 Heart Failure Outcomes 
DAIC
JANUARY 29, 2024
years after SAVR to assess their outcomes. Secondary outcomes included rates of reoperation, infective endocarditis, stroke, and hospital admissions for heart failure. The research team followed these patients for a median time of 2.4 years after TAVR and 4.9 The primary focus was on 5-year survival rates.
Circulation: Cardiovascular Quality & Outcomes
JANUARY 27, 2025
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. BACKGROUND:The absence of practice standards in vasoactive agent usage for acute decompensated heart failure has resulted in significant treatment variability across hospitals, potentially affecting patient outcomes. in 2013 to 48.6% to 77.8%.
Circulation: Cardiovascular Interventions
MARCH 17, 2025
In multivariable analyses, the risk of 1-year heart failure readmission for ventricular functional MR was not higher than for DMR (P=0.10642), while patients with chronic ischemic MR and atrial MR had a 19% higher risk of 1-year heart failure readmission compared with DMR (P=0.00493) even if they had a successful procedure.
Cardiometabolic Health Congress
AUGUST 30, 2024
This discussion explores the principles and practices of evidence-based cardiometabolic medicine, emphasizing the importance of integrating the latest research findings into clinical decision-making to improve patient outcomes. Heart Failure : Home-based cardiac rehabilitation is as effective as center-based programs.
Open Heart
DECEMBER 7, 2023
Objective This study aimed to investigate the association between heart failure (HF) severity measured based on brain natriuretic peptide (BNP) levels and future bleeding events after percutaneous coronary intervention (PCI). The secondary outcome was major adverse cardiovascular events (MACE).
Circulation: Heart Failure
JANUARY 26, 2024
Circulation: Heart Failure, Ahead of Print. CONCLUSIONS:Bariatric surgery and pharmacotherapies with weight loss effects are associated with a lower risk of adverse outcomes among older patients with HF and obesity; however, overall utilization remains low. In propensity-matched analysis over a median follow-up of 2.8
DAIC
JULY 24, 2024
The collaboration, according to a written statement issued by the company, aims to address challenges in capturing and analyzing cardiac signals to help physicians enhance patient outcomes for atrial fibrillation procedures. Am J Cardiol 2013; 112:1142–1147. 1 Approximately 33 million patients worldwide are living with AFib.
Expert insights. Personalized for you.
111 
Let's personalize your content